Venom Biologics Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $30K

  • Investors
  • 1

Venom Biologics General Information

Description

Developer of non-opioid chronic pain treatments designed for targeted ion channel modulation. The company offers non-opioid analgesics, engineered venom peptides, chronic pain treatments, NaV1.8 inhibitors, peripheral pain modulators, and peptide-based therapeutics, enabling chronic pain patients to manage symptoms through engineered peptides derived from scorpion venom.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Dallas, TX
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Dallas, TX
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Venom Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 10-Sep-2026 $30K Completed Startup
To view Venom Biologics’s complete valuation and funding history, request access »

Venom Biologics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Health Wildcatters Accelerator/Incubator Minority
To view Venom Biologics’s complete investors history, request access »

Venom Biologics FAQs

  • Where is Venom Biologics headquartered?

    Venom Biologics is headquartered in Dallas, TX.

  • What industry is Venom Biologics in?

    Venom Biologics’s primary industry is Drug Discovery.

  • Is Venom Biologics a private or public company?

    Venom Biologics is a Private company.

  • What is the current valuation of Venom Biologics?

    The current valuation of Venom Biologics is .

  • What is Venom Biologics’s current revenue?

    The current revenue for Venom Biologics is .

  • How much funding has Venom Biologics raised over time?

    Venom Biologics has raised $30K.

  • Who are Venom Biologics’s investors?

    Health Wildcatters has invested in Venom Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process